{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:27:28Z","timestamp":1790108848511,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00901"],"award-info":[{"award-number":["PI18\/00901"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01804"],"award-info":[{"award-number":["PI18\/01804"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01248"],"award-info":[{"award-number":["PI21\/01248"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD20\/00083"],"award-info":[{"award-number":["CD20\/00083"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI-0310-2018"],"award-info":[{"award-number":["PI-0310-2018"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["POSTDOC_21_00780"],"award-info":[{"award-number":["POSTDOC_21_00780"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA17112"],"award-info":[{"award-number":["CA17112"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009473","name":"Universidad de M\u00e1laga","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nitrofurantoin is a synthetic antibiotic that is recommended as first-choice treatment for uncomplicated urinary tract infections. The prescription of this drug has increased dramatically, especially in Latin American countries. We described the demographics, clinical characteristics, biochemical features, and outcome of nitrofurantoin-induced liver injury. We analyzed 23 cases from the Latin American DILI Network (LATINDILI) and the Spanish DILI Registry. Causality was assessed with the RUCAM and RECAM scale. Of the 23 DILI cases included in our series, 96% patients were women, and the mean age of the whole cohort was 61\u00a0years. The median time of drug exposure was 175\u00a0days (interquartile range [IQR] 96\u2013760), with 11 patients who were prescribed nitrofurantoin for more than six\u00a0months. Hepatocellular damage was the most frequent pattern of liver injury (83%), and nearly half of the patients had an asymptomatic presentation (52%). Neither death nor liver transplantation was documented in this series. Overall, 65% of the patients (<jats:italic>n<\/jats:italic>\u2009=\u200915) presented with positive autoantibody titres. The median time to resolution was 81\u00a0days (IQR 57\u2013141), and 15 patients (83%) recovered within six\u00a0months. Five patients (22%) developed nitrofurantoin-induced autoimmune-like hepatitis (NI-AILH), of whom two were characterized by a persistent increase in transaminases that required immunosuppressive treatment to achieve normalization of liver enzymes. Clinicians who prescribe nitrofurantoin should be aware that patients who had taken nitrofurantoin for a long term may be at risk of developing nitrofurantoin-induced autoimmune-like hepatitis.<\/jats:p>","DOI":"10.1007\/s00204-022-03419-7","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T07:03:12Z","timestamp":1669186992000},"page":"593-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-8123","authenticated-orcid":false,"given":"Fernando","family":"Bessone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6816-3699","authenticated-orcid":false,"given":"Nelia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-9908","authenticated-orcid":false,"given":"Manuel","family":"Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3321-0683","authenticated-orcid":false,"given":"Ezequiel","family":"Ridruejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Zerega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3990-5790","authenticated-orcid":false,"given":"Maria Virginia","family":"Reggiardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Vorobioff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-4191","authenticated-orcid":false,"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8717-6196","authenticated-orcid":false,"given":"Martin","family":"Tagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0471-6658","authenticated-orcid":false,"given":"Inmaculada","family":"Medina-Caliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-2787","authenticated-orcid":false,"given":"Mercedes","family":"Robles-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-3972","authenticated-orcid":false,"given":"Hao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-0604","authenticated-orcid":false,"given":"Ismael","family":"Alvarez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-9610","authenticated-orcid":false,"given":"Camilla","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-4896","authenticated-orcid":false,"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-0757","authenticated-orcid":false,"given":"Raul J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"3419_CR1","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (2016). https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2016\/ni-muh_fv_16-nitrofurantoina. Accessed 21 Sept 2022"},{"key":"3419_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ et al (2011) Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 89:806\u2013815. https:\/\/doi.org\/10.1038\/clpt.2011.58","journal-title":"Clin Pharmacol Ther"},{"key":"3419_CR3","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"RJ Andrade","year":"2019","unstructured":"Andrade RJ, Aithal GP, Bj\u00f6rnsson ES et al (2019) EASL Clinical Practice Guidelines: drug-induced liver injury. J Hepatol 70:1222\u20131261. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"key":"3419_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-1947-4-311","volume":"4","author":"S Appleyard","year":"2010","unstructured":"Appleyard S, Saraswati R, Gorard DA (2010) Autoimmune hepatitis triggered by nitrofurantoin: a case series. J Med Case Rep 4:1\u20135. https:\/\/doi.org\/10.1186\/1752-1947-4-311","journal-title":"J Med Case Rep"},{"key":"3419_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/00365521.2017.1291719","volume":"52","author":"ES Bj\u00f6rnsson","year":"2017","unstructured":"Bj\u00f6rnsson ES (2017) Drug-induced liver injury due to antibiotics. Scand J Gastroenterol 52:617\u2013623. https:\/\/doi.org\/10.1080\/00365521.2017.1291719","journal-title":"Scand J Gastroenterol"},{"key":"3419_CR6","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S et al (2010) Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 51:2040\u20132048. https:\/\/doi.org\/10.1002\/hep.23588","journal-title":"Hepatology"},{"key":"3419_CR7","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","volume":"144","author":"ES Bj\u00f6rnsson","year":"2013","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK et al (2013) Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 144:1419-1425.e3. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.006","journal-title":"Gastroenterology"},{"key":"3419_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15378","author":"ES Bj\u00f6rnsson","year":"2022","unstructured":"Bj\u00f6rnsson ES, Stephens C, Atallah E et al (2022) A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry. Liver Int. https:\/\/doi.org\/10.1111\/liv.15378","journal-title":"Liver Int"},{"key":"3419_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R et al (2015) Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology 148:1340-1352.e7. https:\/\/doi.org\/10.1053\/j.gastro.2015.03.006","journal-title":"Gastroenterology"},{"key":"3419_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","volume":"116","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Maddur H, Russo MW et al (2021) ACG Clinical Guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 116:878\u2013898. https:\/\/doi.org\/10.14309\/ajg.0000000000001259","journal-title":"Am J Gastroenterol"},{"key":"3419_CR11","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/jgs.14796","volume":"65","author":"K Claussen","year":"2017","unstructured":"Claussen K, Stocks E, Bhat D et al (2017) How common are pulmonary and hepatic adverse effects in older adults prescribed nitrofurantoin? J Am Geriatr Soc 65:1316\u20131320. https:\/\/doi.org\/10.1111\/jgs.14796","journal-title":"J Am Geriatr Soc"},{"key":"3419_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","volume":"15","author":"YS de Boer","year":"2017","unstructured":"de Boer YS, Kosinski AS, Urban TJ et al (2017) Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol 15:103-112.e2. https:\/\/doi.org\/10.1016\/j.cgh.2016.05.043","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3419_CR13","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG et al (2011) International Clinical Practice Guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103\u2013e120. https:\/\/doi.org\/10.1093\/cid\/ciq257","journal-title":"Clin Infect Dis"},{"key":"3419_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/hep.32327","volume":"76","author":"PH Hayashi","year":"2022","unstructured":"Hayashi PH, Lucena MI, Fontana RJ et al (2022) A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology 76:18\u201331. https:\/\/doi.org\/10.1002\/hep.32327","journal-title":"Hepatology"},{"key":"3419_CR15","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/jac\/dkv147","volume":"70","author":"A Huttner","year":"2015","unstructured":"Huttner A, Verhaegh EM, Harbarth S et al (2015) Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother 70:2456\u20132464. https:\/\/doi.org\/10.1093\/jac\/dkv147","journal-title":"J Antimicrob Chemother"},{"key":"3419_CR16","doi-asserted-by":"publisher","first-page":"bcr2013203136","DOI":"10.1136\/bcr-2013-203136","volume":"2014","author":"T Hydes","year":"2014","unstructured":"Hydes T, Wright M, Jaynes E, Nash K (2014) Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication. BMJ Case Rep 2014:bcr2013203136. https:\/\/doi.org\/10.1136\/bcr-2013-203136","journal-title":"BMJ Case Rep"},{"key":"3419_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3947\/ic.2018.50.1.67","volume":"50","author":"CI Kang","year":"2018","unstructured":"Kang CI, Kim J, Park DW et al (2018) Clinical Practice Guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother 50:67\u2013100. https:\/\/doi.org\/10.3947\/ic.2018.50.1.67","journal-title":"Infect Chemother"},{"key":"3419_CR18","doi-asserted-by":"publisher","first-page":"272.e1","DOI":"10.1016\/j.ajog.2021.04.218","volume":"225","author":"JL Langner","year":"2021","unstructured":"Langner JL, Chiang KF, Stafford RS (2021) Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women. Am J Obstet Gynecol 225:272.e1-272.e11. https:\/\/doi.org\/10.1016\/j.ajog.2021.04.218","journal-title":"Am J Obstet Gynecol"},{"key":"3419_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN et al (2020) Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 72:671\u2013722. https:\/\/doi.org\/10.1002\/hep.31065","journal-title":"Hepatology"},{"key":"3419_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijantimicag.2019.06.015","volume":"54","author":"K Malmros","year":"2019","unstructured":"Malmros K, Huttner BD, McNulty C et al (2019) Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: results of an online survey. Int J Antimicrob Agents 54:478\u2013486. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.015","journal-title":"Int J Antimicrob Agents"},{"key":"3419_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmi.2016.08.003","volume":"23","author":"AE Muller","year":"2017","unstructured":"Muller AE, Verhaegh EM, Harbarth S et al (2017) Nitrofurantoin\u2019s efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials. Clin Microbiol Infect 23:355\u2013362. https:\/\/doi.org\/10.1016\/j.cmi.2016.08.003","journal-title":"Clin Microbiol Infect"},{"key":"3419_CR22","first-page":"229","volume":"80","author":"C Nemirovsky","year":"2020","unstructured":"Nemirovsky C, L\u00f3pez Furst MJ, Pryluka D et al (2020) Argentine intersociety consensus on urinary infection 2018\u20132019 - Part I [Consenso argentino intersociedades de infecci\u00f3n urinaria 2018\u20132019 - Parte I]. Medicina (b Aires) 80:229\u2013240","journal-title":"Medicina (b Aires)"},{"key":"3419_CR23","doi-asserted-by":"publisher","first-page":"175628721882408","DOI":"10.1177\/1756287218824089","volume":"11","author":"JA Ortega Martell","year":"2019","unstructured":"Ortega Martell JA, Naber KG, Milhem Haddad J et al (2019) Prevention of recurrent urinary tract infections: bridging the gap between clinical practice and guidelines in Latin America. Ther Adv Urol 11:1756287218824089. https:\/\/doi.org\/10.1177\/1756287218824089","journal-title":"Ther Adv Urol"},{"key":"3419_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7326\/0003-4819-92-1-14","volume":"92","author":"JR Sharp","year":"1980","unstructured":"Sharp JR, Ishak KG, Zimmerman HJ (1980) Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med 92:14\u201319. https:\/\/doi.org\/10.7326\/0003-4819-92-1-14","journal-title":"Ann Intern Med"},{"key":"3419_CR25","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.4081\/cp.2012.e83","volume":"2","author":"JM Sherigar","year":"2012","unstructured":"Sherigar JM, Fazio R, Zuang M, Arsura E (2012) Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease. Clin Pract 2:e83. https:\/\/doi.org\/10.4081\/cp.2012.e83","journal-title":"Clin Pract"},{"key":"3419_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/hep.1840080327","volume":"8","author":"BH Stricker","year":"1988","unstructured":"Stricker BH, Blok AP, Claas FH et al (1988) Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology 8:599\u2013606. https:\/\/doi.org\/10.1002\/hep.1840080327","journal-title":"Hepatology"},{"key":"3419_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jac\/33.3.387","volume":"33","author":"JF Westphal","year":"1994","unstructured":"Westphal JF, Vetter D, Brogard JM (1994) Hepatic side-effects of antibiotics. J Antimicrob Chemother 33:387\u2013401. https:\/\/doi.org\/10.1093\/jac\/33.3.387","journal-title":"J Antimicrob Chemother"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-022-03419-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T15:09:40Z","timestamp":1674227380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-022-03419-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3419"],"URL":"https:\/\/doi.org\/10.1007\/s00204-022-03419-7","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}